dr. m. alzaharna 2015 labeled immunoassay lab. 2
TRANSCRIPT
Dr. M. Alzaharna 2015
LABELED IMMUNOASSAY
Lab. 2
Dr. M. Alzaharna 2015 2
Immunoassay• An immunoassay is a test that uses antibody and antigen complexes as a mean of generating a measurable result
• Immuno refers to an immune response that causes the body to generate antibodies,
• and assay refers to a test
• An antibody-antigen complex is also known as an immuno-complex
• The assay takes advantage of the specific binding of an antibody to its antigen
• The antibodies used must have a high affinity for the antigen
Dr. M. Alzaharna 2015 3
Immunoassays
• Immunoassays derive their unique specificity, sensitivity, and flexibility from three important properties of antibodies:• Their ability to bind to an extremely wide range of
natural and man-made chemicals, biomolecules, cells, and viruses
• Exceptional specificity for the substance to which each antibody binds.
• The strength of the binding between an antibody and its target
Dr. M. Alzaharna 2015 4
Immunoassay
• Both the presence of antigen or antibody can be measured• For measuring hormones such as insulin, the insulin
acts as the antigen• When detecting infection the presence of antibody
against the pathogen is measured
• For numerical results the response of the object being measured must be compared to standards of a known concentration
• This is usually done through the plotting of a standard curve on a graph paper, and then the quantity of the unknown is found from the curve
Dr. M. Alzaharna 2015 5
Types of Tests
• Many methods of varying sophistication are used for immunodiagnostic studies
Dr. M. Alzaharna 2015
Visible Change Observable Reaction Name of Test
Clumping Particulate antigen reacts with corresponding antibody; antigen may be in form of RBCs (hemagglutination, latex, or charcoal coated with antigen).
Agglutination
Precipitates Soluble antigen reacts with corresponding antibody Precipitation
Complement activation, hemolysis
Competition between two antigen-antibody systems (test and indicator systems)
Complement fixation (CF)
Visible microscopic fluorescence
Fluorescent-tagged antibody reacts with antigen-antibody complex in the presence of ultraviolet light.
Immunofluorescence
Color change indicates enzyme substrate reaction.
Indirect EIA for quantification of an antigen or antibody enzyme and substrate
Enzyme-linked immunosorbent assay
(ELISA)
Detection of antibodies of specific mobility
Electrophoresis separation of antigen subspecies Immunoblot (eg, Western blot [WB])
Light scatter proportionately increases as numbered size of immune complexes increases.
Measures either antigen or antibody in solution through the scattering of a light beam; antibody reagent used to detect antigen IgA, IgG, IgM; concurrent controls are run to establish amount of background scatter in reagents and test samples.
Rate nephelometry
6
Types of Tests
Dr. M. Alzaharna 2015 7
Rate nephelometry
Dr. M. Alzaharna 2015 7
Antigen-antibody interaction• Antigens are substances that stimulate and subsequently
react with the products of an immune response. They may be:• Enzymes, • Toxins, • Microorganisms (eg, bacterial, viral, parasitic, fungal), • Tumors, • Autoimmune factors
• Antibodies are proteins produced by the body's immune system in response to an antigen or antigens.
• The antigen-antibody response is the body's natural defense against invading organisms
Dr. M. Alzaharna 2015 8
SSSS
Light Chain
Light ChainSS
SS
Antibody Structure
Constant Constant
Constant Constant
VV
V
V
Antigen binding site
Antigen binding site
Heavy Chains
Dr. M. Alzaharna 2015 9
Antigen Binding
Variable
Light
Variable
Heavy
Antigen 1Antigen 3
Antigen 2
Dr. M. Alzaharna 2015 11
History
• In the year 1959, Drs. Rosalyn Yalow & Soloman Berson invented the radioimmunoassay (RIA)
• Applied the use of radioisotopes in the measurement of insulin
• The RIA is the predecessor of modern immunoassays Dr. Rosalyn Yalow became the first
female to win a Nobel Prize withher work on the radioimmunoassay
Dr. M. Alzaharna 2015 12
Current Situation• There are now hundreds of immunoassays for dozens of
analytes including:
• covering the fields of:
• Developments in antibodies, labels, and automation have resulted in highly specific and sensitive assays
• Hormones • Tumor markers • Antibodies
• Drugs • Cardiac markers
• Endocrinology • Oncology • Hematology
• Toxicology • Immunology • Infectious diseases
Dr. M. Alzaharna 2015 13
Constituents of a Labeled Immunoassay
• For detection of an analyte, the following are usually a part of the assay:
1. Labeled analytes
2. Specific antibody
3. Standards or calibrators
4. A method to separate the bound from free components
5. A method for detection of the label
Dr. M. Alzaharna 2015 14
1- Labeled Analytes• A labeled analyte is used to detect whether or not specific
binding has taken place• The label used in immunoassay:
• must not alter the reactivity of the molecule• and it should remain stable for the shelf life of the reagent
• Labels attached to analytes and antibodies can be:• Radioactive
• usually iodine-125 (radioimmunoassay),
• Enzymes • such as alkaline phosphatase and horseradish peroxidase, (enzyme
immunoassay or enzyme-linked immunosorbent assay [ELISA]),
• Chemiluminescent • e.g. acridinium ester
• Fluorescent • e.g. fluorscein
Dr. M. Alzaharna 2015 15
Methods of coupling indicator labels to antigen or antibody
• The Methods include:
A. Binding to amino acids• The radioactive isotope iodine is
covalently linked to tyrosine residues present on antibodies and most antigens
Dr. M. Alzaharna 2015 16
Methods of coupling indicator labels to antigen or antibody
B. Using glutaraldhyde • It is a bifunctional reagent
that covalently cross links two aminoacids together, reacts with amine groups
• Fluorochromes or enzymes may be coupled to antigens or antibodies using glutaraldhyde
Dr. M. Alzaharna 2015 17
Methods of coupling indicator labels to antigen or antibody
C. Biotin-Streptavidin system• Biotin is a vitamin that can bind tightly to either avidin or
streptavidin (proteins) • The natural attraction of biotin to these two proteins is a
property that has been exploited to facilitate coupling of indicator molecules to antigens or antibodies
• At the end of the assay, a conjugate of streptavidin linked to a signal-generating substance is added• Examples of suitable conjugates are streptavidin-alkaline phosphatase,
streptavidin-HRP, streptavidin-125I, streptavidin fluorescein
Dr. M. Alzaharna 2015 18
The biotin-Streptavidin indicator label system
Dr. M. Alzaharna 2015 19
2- Production of Antibodies
• The production of antibodies is an important process in the use of immunoassays because it is the antibody-antigen complexes that form the basic
• Antibodies can be called depending upon the technique used to produce them either:a) Monoclonal or
b) Polyclonal
Dr. M. Alzaharna 2015 20
a) Polyclonal Antibodies
• May be produced in mammals such as rabbits or sheep
• When a foreign substance enters the body, it stimulates the immune system to produce antibodies to the substance
• Using this natural reaction, an analyte in as pure form as possible is injected into the animal stimulating the production of antibodies
• Antiserum usually contains a mixture of antibodies that recognize and bind to the same antigen, but they may attach to different epitopes
Dr. M. Alzaharna 2015 21
a) Polyclonal Antibodies
Ag Ag
Multivalent Antigen complex
Polyclonal Antibodies Antibody-Antigen complex
Dr. M. Alzaharna 2015 22
b) Monoclonal Antibodies
• Monoclonal antibodies production result in very specific antibodies that bind only to one antigen epitope, which in turn reduces the occurrence of false positives in the immunoassay
Multivalent Antigen complex
Monoclonal Antibodies Antibody-Antigen complex
Ag Ag
Dr. M. Alzaharna 2015 23
b) Monoclonal Antibodies
Dr. M. Alzaharna 2015 24
3- Standards or calibrators
• By running a set of calibrators, a calibration curve is set up in the instrument’s software and correlates certain values of signal to known analyte concentrations
• By comparing levels of signal produced by patient samples to this calibration curve, a patient analyte concentration value, or result, can be determined
• Calibrators are solutions with known values that establish the relationship between the amount of signal produced in the assay and analyte concentration
Dr. M. Alzaharna 2015 25
4- Separation Methods• In most assays, once the reaction between antigen and
antibody has taken place, there must be a way of separating reacted from unreacted analyte
• This can be accomplished by several different means• Unreacted analyte can be removed by:
• Adsorption on particles such as dextran-coated charcoal• These adsorb out the smaller unbound molecules, which are then
separated from bound molecules by centrifugation or filtration
• The amount of label remaining in the supernatant provides an indirect measure of analyte present in the patient's sample
• Another means of separation involves precipitation of antigen-antibody complexes• Complexes can be precipitated by adding concentrated solutions of
ammonium sulfate, or ethanol
Dr. M. Alzaharna 2015 26
4- Separation Methods
• Currently, most immunoassays use a solid-phase stage for separation
• Numerous substances, such as polystyrene test tubes, microtiter plates are used for this purpose
• Antigen or antibody is attached by physical adsorption, and when specific binding takes place, complexes remain attached to the solid phase
• This provides a simple way to separate bound and free reactants
Dr. M. Alzaharna 2015 27
Dr. M. Alzaharna 2015 28
5- Methods for detection of label
• The last step common for all immunoassays is detection of the labeled analyte
• The method depends on the label; • e.g. 125I is easily detected by a γ-counter • Enzymes are generally used to produce coloured
products from colourless substrates that can be determined easily using a spectrophotometer• Automated plate readers are commercially available which make
reading large numbers of samples relatively easy
Dr. M. Alzaharna 2015 29
Quality Control in Immunoassays
• It is essential that quality control procedures be established
• This is done to limit random errors, such as• temperature fluctuations• minor changes in the concentration of reagents• and changes in detector efficiency
• A negative control and a positive control should be run
• This serves as a check on the quality of the reagents to make sure that the label is readily detectable under current testing conditions
Dr. M. Alzaharna 2015 30
Methodological Principles
1. Competitive Immunoassays2. Noncompetitive Immunoassays3. Heterogeneous Immunoassays4. Homogeneous Immunoassays
Dr. M. Alzaharna 2015 31
Specific Ab
Ag L antigen- enzyme conjugate
immobilisation surface
L
L
S
P
Enzym. reaction
Productmeasurement
L
Incubation
LL
Coating
1- Competitive Immunoassays
• Based on competition between the analyte in the sample and a labeled analyte for a limited mount of antibody
Dr. M. Alzaharna 2015 32
1- Competitive Immunoassays
Dr. M. Alzaharna 2015 33
2- Noncompetitive Immunoassays• Noncompetitive immunoassays (Sandwich) generally
provide the highest level of assay sensitivity and specificity• The reaction mixture typically includes an excess of labeled antibody,
so that all analyte is bound• The amount of antibody-antigen complex is then measured to
determine the amount of analyte present in the sample• The labeled antibody, is directly proportional to the amount of antigen
present in the sample
Dr. M. Alzaharna 2015 34
Homogeneous versus Heterogeneous Immunoassays
3- Heterogeneous Immunoassay • Methods that require separation of bound Ab-Ag* complex
4- Homogeneous Immunoassay • Those that do not require separation • Homogeneous methods have been generally applied to the
measurement of small analytes such as abused and therapeutic drugs
• Since homogeneous methods do not require the separation of the bound Ab-Ag* from the free Ag*, they are generally much easier and faster to perform
Dr. M. Alzaharna 2015 35
Homogeneous Immunoassays
Substrate Substrate reacting with enzyme
Drug blocking Drug attached to enzymeAntibody
Drug
Enzyme with Drug attached
Dr. M. Alzaharna 2015 36
• Radioimmunoassays (RIAs) • utilize a radioactive label
(usually 125I, 3H or 14C), which emits radiation that can be measured with a beta or gamma counter
• Within the categories of competitive, noncompetitive, homogenous, and heterogeneous, there are specific types, which include:
Types of Immunoassays (Heterogeneous)
Dr. M. Alzaharna 2015 37
Types of Immunoassays (Heterogeneous)
• Enzyme linked immunosorbant assay (ELISA): • Direct, sandwich and
competitive• Reaction components are
absorbed or bound to the surface of a solid phase, commonly a well of a microtiter plate
• Absorbance is measured using a micro-plate reader
Dr. M. Alzaharna 2015 38
Types of Immunoassays (Homogeneous)
• Enzyme Multiplied Immunoassay (EMIT)• The drug in the sample and the
drug labeled with G6PD compete for antibody binding sites
• Binding inhibits enzyme activity, while free enzyme remains active to interact with the substrate
• Enzyme activity/absorbance is directly proportional to drug concentration.
Substrate Substrate reacting with enzyme
Drug blocking Drug attached to enzymeAntibody
Drug
Enzyme with Drug
attached
Dr. M. Alzaharna 2015 39
Immunoassay Results• Qualitative
• Single point calibration at a specific cutoff
• Results are either ‘positive’ or ‘negative’ (i.e. above or below the cutoff)
• Quantitative• Provides numeric results that are an estimate the analyte
concentration based on the measurement standards
Dr. M. Alzaharna 2015
Rubella IgM Test Kit
Dr. M. Alzaharna 2015 41
Intended Use
• Rubella IgM ELISA test is an enzyme linked immunosorbent assay (ELISA) for the detection of IgM class antibodies to Measles (Rubella) in human serum or plasma
•
Dr. M. Alzaharna 2015 42
Summary and explanation• Measles is an acute, highly contagious viral disease.• Although measles is usually considered a childhood disease, it
can be contracted at any age. • Measles is spread by direct contact with nasal or throat
secretions of infected people or, less frequently, by airborne transmission.
• Measles symptoms generally appear in two stages. • In the first stage, the individual may have a runny nose, cough and a
slight fever. • The second stage begins on the third to seventh day and consists of
high fever and red blotchy rash lasting four to seven days. • The rash usually begins on the face and then spreads over the entire
body. • Symptoms usually appear in 10-12 days, although they may occur
between 8-13 days after exposure.
Dr. M. Alzaharna 2015 43
Summary and explanation
• The presence of IgG antibody to Rubella virus is indicative of previous exposure or vaccination.
• In individuals with acute measles, a significant increase in measles IgG antibody level is indicative of recent infection.
• IgM antibodies to Rubella virus are often detectable with onset of the rash and typically persist for 4 weeks.
• At least 80% of patients will be positive for Rubella IgM at 6 days and 100% at 16 days after onset of symptoms.
Dr. M. Alzaharna 2015 44
Principle• Diluted patient serum is added to wells coated with
purified Rubella antigen. • Rubella IgM specific antibody, if present, binds to the
antigen. • All unbound materials are washed away and the
enzyme conjugate is added to bind to the antibody-antigen complex, if present.
• Excess enzyme conjugate is washed off and substrate is added.
• The plate is incubated to allow the hydrolysis of the substrate by the enzyme.
• The intensity of the color generated is proportional to the amount of IgM specific antibody in the sample.
Dr. M. Alzaharna 2015 45
Procedure
1. Bring all specimens and kit reagents to room temperature (18-26 °C) and gently mix.
2. Place the desired number of coated strips into the holder.
3. Negative control, positive control, and calibrator are ready to use. Prepare 1:21 dilution of test samples, by adding 10 μl of the sample to 200 μl of sample diluent. Mix well.
4. Dispense 100 μl of diluted sera, calibrator and controls into the appropriate wells. For the reagent blank, dispense 100μl sample diluent in 1A well position. Tap the holder to remove air bubbles from the liquid and mix well. Incubate for 20 minutes at room temperature.
5. Remove liquid from all wells. Wash wells three times with 300 μl of 1X wash buffer. Blot on absorbance paper or paper towel.
Dr. M. Alzaharna 2015 46
Procedure
6. Dispense 100 μl of enzyme conjugate to each well and incubate for 20 minutes at room temperature.
7. Remove enzyme conjugate from all wells. Wash wells three times with 300 μl of 1X wash buffer. Blot on absorbance paper or paper towel.
8. Dispense 100 μl of TMB substrate and incubate for 10 minutes at room temperature. Add 100 μl of stop solution.
9. Read O.D. at 450 nm using ELISA reader within 15 min.
10. A dual wavelength is recommended with reference filter of 600-650 nm.
Dr. M. Alzaharna 2015 47
Calculation of results
1. Check Calibrator Factor (CF) value on the calibrator bottle. This value might vary from lot to lot. Make sure you check the value on every kit.
2. Calculate the cut-off value: • Calibrator OD x Calibrator Factor (CF).
3. Calculate the Ab (Antibody) Index of each determination by dividing the O.D. value of each sample by cut-off value.
Dr. M. Alzaharna 2015 48
Example of typical results
• Calibrator mean OD = 0.8 • Calibrator Factor (CF) = 0.5 • Cut-off Value = 0.8 x 0.5= 0.400 • Positive control O.D. = 1.2
• Ab Index = 1.2 / 0.4 = 3
• Patient sample O.D. = 1.6 • Ab Index = 1.6 / 0.4 = 4.0
Dr. M. Alzaharna 2015 49
Validation requirement and quality control
1. The O.D. of the Calibrator should be greater than 0.250.
2. The Ab index for Negative control should be less than 0.9.
3. The Ab Index for Positive control should be greater than 1.2.
Dr. M. Alzaharna 2015 50
Interpretation of results
• The following is intended as a guide to interpretation of Measles IgM test results; each laboratory is encouraged to establish its own criteria for test interpretation based on sample populations encountered.
• Antibody Index Interpretation • < 0.9 No detectable Ab to Rubella IgM by ELISA.• 0.9 – 1.1Borderline positive, follow up testing is
recommended if clinically indicated.• > 1.1 Detectable antibody to measles IgM by ELISA.